Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Sanofi (SNY)

-NYSE
49.97 Up 1.17(2.40%) Mar 27, 4:00PM EDT
|After Hours : 49.97 0.00 (0.00%) Mar 27, 5:16PM EDT
Add to Portfolio
Prev Close:48.80
Open:49.55
Bid:50.01 x 100
Ask:52.10 x 100
1y Target Est:55.00
Beta:1.15
Next Earnings Date:N/A
Day's Range:49.36 - 50.13
52wk Range:43.57 - 57.42
Volume:1,057,851
Avg Vol (3m):2,204,960
Market Cap:130.67B
P/E (ttm):28.38
EPS (ttm):1.76
Div & Yield:1.62 (3.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNYUp 2.40%130.67B
GSKUp 0.77%113.11B
MRKUp 0.26%163.91B
PFEUp 1.08%211.63B

Key Statistics

Forward P/E (1 yr):15.62
P/S (ttm):3.51
Ex-Dividend Date:06-May-15

Analysts

Annual EPS Est (Dec-15) :3.13
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):2.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback